AzTrials
AzTrials

ParentingNCT02622048

Understanding and Helping Families: Parents With Psychosis

A study testing Triple P Positive Parenting Programme in people with Parenting and Psychosis, run by University of Manchester at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this trial is to explore parent-child interactions in parents with and without psychosis, and ascertain whether a brief (10 week) supported self-help parenting program offered to parents in their own homes can help improve parents' self-efficacy and general well-being, as well as interpretations of… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Parenting, Psychosis, Schizophrenia
What is being tested?
Triple P Positive Parenting Programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited Kingdom
Study dates
Sep 2015to Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Presence of ICD-10 schizophrenia-spectrum diagnosis (F20-29).
  • Primary parental caregiver for index child. This includes 10 hours of contact time with their child.
  • Over 18 years of age.
  • Have at least one child aged 3-10 years old.
  • Identify difficulties in parenting during assessment.
  • Proficient in written and spoken English.
  • Capacity to provide informed consent.

Who cannot join

  • Parents with a schizophrenia-spectrum diagnosis who have recently been discharged from acute in-patient care, and have less than four weeks of stabilisation. This will enable the individual sufficient time to readjust to living in the community and ensure symptom stabilisation before taking part in a study.
  • Parents who have no regular contact with the index child or where there is known intention for their child to be removed.
  • Parents who present with child protection of safeguarding issues.
  • Parents seeking or receiving support from services regarding child management issues.
  • Parents actively involved in other structured programmes.
  • Inclusion Criteria matched comparison group of parents for stage 1
Show all 20Show fewer
  • The comparison group of parents will be matched for age, education, socioeconomic status and family composition where possible
  • No previous history of psychotic illnesses.
  • Primary parental caregiver for index child. This includes 10 hours of contact time with their child.
  • Over 18 years of age.
  • Have at least one child aged 3-10 years old.
  • Identify difficulties in parenting during assessment.
  • Proficient in written and spoken English.
  • Capacity to provide informed consent.
  • Parents with schizophrenia-spectrum symptoms, diagnosis or history.
  • Parents who have no regular contact with the index child or where there is known intention for their child to be removed.
  • Parents seeking support from services regarding child management issues.
  • Parents actively involved in other structured programmes.
  • Parents/caregivers who do not have good working knowledge of English. They should have enough practical experience to be able to adequately use the English language to understand and respond to questions and to read and complete questionnaires.
  • Insufficient language or cognitive ability to participant fully or provide informed consent.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site, 1 recruiting
  • The University of Manchester

    Manchester, Lancashire, M139PL

    Lauren Stockton, 01613062619

    Lauren Stockton

    Recruiting

Other trials in United Kingdom

About this study

Official title: STAGE 1: Investigating Attributions and Expressed Emotion in Parents With and Without Psychosis STAGE 2: Investigating the Use of a Self-directed Parenting Programme With Parents Experiencing Psychosis

The purpose of this trial is to explore parent-child interactions in parents with and without psychosis, and ascertain whether a brief (10 week) supported self-help parenting program offered to parents in their own homes can help improve parents' self-efficacy and general well-being, as well as interpretations of their parent-child relationship and child behaviour in children who are 3-10 years old.

Read the detailed description

The trial will be split into two stages.

Stage 1: Parents with no history of serious mental health problems and parents who have a history of psychosis or schizophrenia, who have children aged 3-10 years old, will take part in the Revised Five Minute Speech Sample (FMSS) and the Modified Camberwell Family Interview (CFI). They will also complete various measures looking at parental well-being, depression, anxiety and stress as well as parenting behaviours and interpretations of their child behaviour. In addition the PANSS interview will also be used. These interviews will be coded to investigate attributional patterns.

Stage 2: Parents who are experiencing psychosis, who took part in stage 1 will proceed to stage 2 if they want to. Parents will be seen weekly and take part in a guided self-help parenting intervention. This will require weekly visits over 10 weeks to the parents. During this time, symptoms, mood, general well-being and parenting behaviours will be monitored.

There will be no randomisation: all parents experiencing psychosis will receive the intervention.

Children do not attend the sessions, but it is hoped that parents practice the skills learned.

Being tested
Triple P Positive Parenting Programme
Keywords
Mental Health, Psychosis, Parent
Medical subject headings
Psychotic Disorders, Schizophrenia, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Triple P Positive Parenting ProgrammeBehavioural

    10 week self-directed (guided) parenting intervention promoting self-belief, parenting confidence/self-efficacy and problem solving skills.

Study groups in NCT02622048
Study groupRoleWhat they receive
Stage 2 Parents experiencing psychosisExperimentalParents all receive the self-directed Triple P Positive Parenting Programme
Receives: Behavioral: Triple P Positive Parenting Programme

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Positive and Negative Syndrome Scale (PANSS)

    Assessment of parental symptoms, mood, behaviours, aswell as social performance and depression

    Measured: Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

  2. Five Minute Speech Sample (FMSS)

    Assessment of Expressed Emotion using a 5 minute uninterrupted interview

    Measured: Initial Ax, End Ax, Follow up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

  3. Modified Camberwell Family Interview (CFI)

    In depth assessment of Expressed Emotion using a modified version of the CFI. This version is for parents of well children.

    Measured: Initial Ax only

Secondary outcomes (5)
  1. Depression, Anxiety and Stress Scale (DASS-21)

    Self-reported depression, anxiety and stress using a short form scale

    Measured: Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

  2. Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

    Self-reported general well-being

    Measured: Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

  3. Eyberg Child Behaviour Inventory (ECBI)

    Parents self-reported child problem behaviour

    Measured: Initial Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

  4. Strengths and Difficulties Questionnaire (SDQ)

    Parents self-reported child behaviour assessing different aspects of behaviour, e.g.,: emotional symptoms, conduct problems, hyperactivity/inattention.

    Measured: Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

  5. Parenting and Family Adjustment Scale (PAFAS)

    An assessment of parenting skills and family relationships.

    Measured: Baseline, 1, 5, 10, follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Dec 2015 (estimated)
  2. Study startSep 2015
  3. Primary completionJul 2017 (estimated)
  4. Study completionJul 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02622048
Sponsor's protocol ID
15209: 15/NW/0532
Status last verified
Jun 2016
First submitted
20 Nov 2015
Last updated
8 Jun 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Triple P Positive Parenting Programme in people with Parenting and Psychosis, run by University of Manchester at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lauren Stockton (07939563467, lauren.stockton@postgrad.manchester.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Positive and Negative Syndrome Scale (PANSS) (time frame: Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in